Firm
Brian Horne reveals how his team secured a favourable damages outcome in a patent and trade secrets case involving X-ray technology
The five-partner team enhances Sheppard Mullin’s technology and life sciences capabilities, expanding its IP practice to more than 130 practitioners
Benjamin Grzimek, partner at Casalonga’s new Düsseldorf office, believes the firm is well-placed to challenge German UPC dominance
A lot of the reporting around the Anthropic settlement misses something critical: it isn’t that relevant to AI training, argues Rebecca Newman at Addleshaw Goddard
Sponsored
Sponsored
-
Sponsored by Bird & BirdMax Walters joins Sally Shorthose and James Baillieu of Bird & Bird and Henry Hadad of Bristol Myers Squibb to discuss how COVID-19 has shaped transactional work -
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law looks ahead at the key deadlines in the South Korean drug patent market for 2021
-
Sponsored by Maiwald Intellectual PropertyChristian Meyer of Maiwald explores a recent decision which prevents the distribution of medicinal products by means of an automatic dispenser from a foreign mail-order pharmacy
-
Sponsored by Liu, Shen & AssociatesXiaoming Zhang of Liu Shen & Associates takes a closer look at the Draft for Comments to the Patent Examination Guidelines and discusses its positive approach towards AI-related applications
-
Sponsored by Vivien Chan & CoExperts from Vivien Chan & Co report on significant developments from the IP world across China and the Asia-Pacific
-
Sponsored by Griffith HackKaren Sinclair and Sarah Cox of Griffith Hack review the Australian federal government’s budget measures for R&D, innovation, and medical technology funding
